Intelecta

Levocarnitine, the active ingredient in Intelecta, is a carnitine presented as a sterile solution for intravenous use. It supports the transport of long‑chain fatty acids into mitochondria, facilitating β‑oxidation and energy production, and is employed in patients with carnitine deficiency or related metabolic disorders. GNH USA supplies Intelecta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, and specialty clinics worldwide, ensuring consistent quality and regulatory compliance across markets. The product is manufactured under strict GMP standards and shipped with appropriate temperature control.

Levocarnitine is used to address carnitine deficiency and related metabolic disturbances.

Primary systemic carnitine deficiency: restores intracellular carnitine levels and improves energy metabolism. Secondary carnitine deficiency (e.g., dialysis): replenishes lost carnitine and supports fatty‑acid oxidation. Metabolic disorders requiring supplementation: enhances β‑oxidation in patients with fatty‑acid oxidation defects. Cardiomyopathy associated with carnitine deficiency: improves myocardial energy utilization and cardiac function.

Levocarnitine may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea or vomiting - Injection‑site pain or erythema - Flushing or warmth sensation - Headache - Mild hypotension - Transient dizziness

Serious or Rare Side Effects: - Anaphylactic or severe hypersensitivity reactions - Cardiac arrhythmias - Metabolic acidosis - Hyperkalemia - Thrombophlebitis at the infusion site - Severe hypotension requiring intervention

Before initiating therapy, clinicians should evaluate patient-specific factors and monitor for potential complications.

Assess baseline carnitine levels: determine need for supplementation. Monitor renal function: adjust dosing in patients with impaired clearance. Observe cardiac status: watch for arrhythmias during infusion. Avoid in patients with known hypersensitivity to levocarnitine or formulation components. Use caution during pregnancy or lactation: only if benefit outweighs risk. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levocarnitine may interact with certain medications, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: may exacerbate carnitine depletion. - Carbamazepine and other enzyme‑inducing antiepileptics: increase carnitine clearance.

Moderate Interactions (Monitor Closely): - Warfarin: monitor INR as carnitine may affect anticoagulation. - Thyroid hormone replacement: assess thyroid function tests. - Insulin or oral hypoglycemics: watch for changes in glucose control. - Diuretics: monitor electrolyte balance, especially potassium.